Evidence map›Paper›PMID 35537236›Full record

SynthesisCortex; a journal devoted to the study of the nervous system and behavior2022

COVID-19 associated cognitive impairment: A systematic review.

José W L Tavares-Júnior, Ana C C de Souza, José W P Borges, Danilo N Oliveira, José I Siqueira-Neto, Manoel A Sobreira-Neto, Pedro Braga-Neto

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Cortex; a journal devoted to the study of the nervous system and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed, 4 pooled it
21.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 4 syntheses or guidelines pooled it, 172 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Cognitive Function 1 Year After COVID Infection.Open forum infectious diseases · 2025
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

José W L Tavares-JúniorDepartment of Clinical Medicine, Universidade Federal do Ceará, Fortaleza, CE, Brazil. Electronic address: wagnerleoneljr@gmail.com.
Ana C C de SouzaHospital Universitário Walter Cantídio (HUWC), Fortaleza-CE, Brazil. Electronic address: anaceliacs.doc@gmail.com.
José W P BorgesDepartment of Nursing, Universidade Federal do Piauí, Teresina, PI, Brazil. Electronic address: josewictoborges@gmail.com.
Danilo N OliveiraDepartment of Clinical Medicine, Universidade Federal do Ceará, Fortaleza, CE, Brazil. Electronic address: danilonunesoliveira@gmail.com.
José I Siqueira-NetoDepartment of Clinical Medicine, Universidade Federal do Ceará, Fortaleza, CE, Brazil. Electronic address: jibiapinaneto@yahoo.com.br.
Manoel A Sobreira-NetoDepartment of Clinical Medicine, Universidade Federal do Ceará, Fortaleza, CE, Brazil. Electronic address: manoelsobreira@yahoo.com.br.
Pedro Braga-NetoCenter of Health Sciences, Universidade Estadual do Ceará, Fortaleza, CE, Brazil. Electronic address: pbraganeto@ufc.br.
Universidade Federal do Ceará · BRHospital Universitário Walter Cantídio · BRUniversidade Estadual do Ceará · BRUniversidade Federal do Piauí · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCOVID-19 has a wide range of clinical manifestations. Neurological manifestations in COVID-19 patients were demonstrated during the pandemic, including cognitive impairment. This study aimed to determine any relationship between COVID-19 and cognitive complaints, such as dementia, mild cognitive impairment (MCI), or subjective cognitive decline (SCD).

methodsWe performed a systematic review of MEDLINE via Ebsco, Cochrane EMBASE, SCOPUS, and LILACS electronic databases of observational studies with COVID-19 patients confirmed by serology or PCR who developed new cognitive impairment or deteriorated from previous cognitive impairment after infection. This review protocol was recorded on PROSPERO with registration number CRD 42021241590.

resultsA total of 3.520 articles were retrieved and read. Twenty-two studies were selected for our review. A wide range of cognitive assessment tools (n = 25) was used. The most described affected domains in these studies were executive functions, attention, and episodic memory. Thirteen studies showed a pattern of cognitive impairment in processing speed, inattention, or executive dysfunction assessed through working memory.

conclusionThis review highlights the high frequency of cognitive impairment after COVID-19 infection. However, we were unable to differentiate whether the cognitive impairment found corresponded to mild cognitive impairment or dementia through data from selected studies, and this issue serves as one objective of future studies to be addressed on this topic.

Indexed as

Cognitive DysfunctionCOVID-19DementiaCognitionExecutive FunctionHumansCognitive impairmentCOVID-19DementiaRisk factorSARS-CoV-2 infection

Identifiers

PMID35537236
PMCPMC9014565
OpenAlexW4223946827

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.